Stem cell exosomes for acute ischemic stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This clinical trial is testing a treatment made from stem cell exosomes — tiny particles that help cells communicate — given through an IV to people who have had a recent ischemic stroke caused by a blood clot. The study aims to see if it's safe and can help recovery when given within the first few days after a stroke.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had an acute ischemic stroke (a stroke caused by a clot). It needs to be in a certain part of the brain (internal carotid artery system).
- Your stroke started within the last 72 hours (about 3 days).
- Your stroke is mild (NIHSS score 1-4) if you're in the single-dose study, or moderate (NIHSS score 5-12) for the multiple-dose study.
- Before the stroke, you were able to do your daily activities without help (mRS score 0 or 1).
- You have not had any bleeding in the brain with this stroke.
- You have not been treated with exosomes before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new treatment using stem cells from donated umbilical cord tissue to help people recover from a recent moderate to severe stroke. It is for patients who cannot receive standard clot-busting treatments.
This trial tests whether umbilical cord stem cells given within a month after a stroke can help patients recover. It is for people with a moderate to moderately severe stroke affecting the front part of the brain.
This trial tests whether stem cells from umbilical cord blood can help the brain recover after a recent stroke. The cells are given as an injection within 48 hours of stroke onset to see if they reduce disability and improve outcomes.
This trial tests whether special cells from human placenta can help your brain recover after a recent stroke. The treatment is given as an injection and aims to reduce long-term disability.
This trial tests whether giving albumin, a protein naturally found in blood, can improve recovery after a large artery stroke when given along with a procedure to remove the clot. It's for people aged 18-80 who have a stroke from a blockage in the front part of the brain and can get treatment within 24 hours.
This trial tests whether exosomes from human stem cells can help people recover after a stroke in the front part of the brain. You must start treatment within one week of the stroke, have a certain level of disability, and be generally healthy otherwise.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.